HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- CAR T-cell therapy approval huge step for oncology, but only ‘beginning of story’
-
- American Society for Radiation Oncology members elect officers
- ASH presents research awards to 12 fellows
- Cancer Treatment Centers of America appoints medical oncology chief
- Durvalumab plus tremelimumab fails to improve PFS in metastatic non-small cell lung cancer
- Improvements needed to better integrate PCPs into cancer survivorship care
- Nivolumab-ipilimumab combination improves response rate in renal cell carcinoma
- Osimertinib extends PFS in non-small cell lung cancer
- Roswell Park department chair receives thoracic surgery award
-
- Rutgers Cancer Institute of New Jersey appoints chief nursing officer
- Trump signs FDA Reauthorization Act of 2017 into law
- University Hospitals Seidman Cancer Center appoints president
- Adjuvant treatment of pancreatic cancer: Hobson’s choice or Morton’s fork? Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA approves Endari for sickle cell disease
- FDA expands Darzalex approval for relapsed myeloma
- FDA grants fast track designation to caplacizumab for rare blood disorder
- FDA grants full approval to Blincyto for acute lymphoblastic leukemia
-
- FDA grants marketing approval to next-generation sequencing test for metastatic colorectal cancer
- FDA grants orphan drug designation to gilteritinib for acute myeloid leukemia
- FDA grants orphan drug designation to SurVaxM for glioblastoma
- FDA grants priority review to abemaciclib for advanced breast cancer
- FDA grants priority review to Sprycel for children with chronic myeloid leukemia
- ASCO updates antiemetic guidelines for cancer treatment
- Clofarabine shows promise as alternative chemotherapy for younger patients with AML
- Emotional distress may lead to unnecessary treatment for prostate cancer
-
- First live births less common among cancer survivors
- Genomic testing for non-small cell lung cancer underused in community-based practices
- HLA–identical sibling HSCT leads to high rate of 5-year survival in sickle cell disease
- ‘Isolation bag’ trial renews debate about power morcellation
- Palliative care reduces aggressive treatment of advanced cancer
- Parkinson disease appears linked to melanoma
- Retroperitoneal exploration improves survival in optimally debulked advanced epithelial ovarian cancer
- Secondhand smoke exposure has declined among most, not all, cancer survivors
-
- Women who experience nausea, vomiting less adherent to preventive breast cancer therapy
- Eculizumab reduces hemolysis, thrombosis in paroxysmal nocturnal hemoglobinuria